Abstract: Within at otal residence time of 9min, the sodium salt of ciprofloxacin was prepared from simple building blocks via al inear sequence of six chemical reactions in five flow reactors.S equential offline acidifications and filtrations afforded ciprofloxacin and ciprofloxacin hydrochloride.T he overall yield of the eight-step sequence was 60 %. No separation of intermediates was required throughout the synthesis when as ingle acylation reaction was applied to remove the main byproduct, dimethylamine.
Continuous flow synthesis has emerged as an efficient technique in synthetic chemistry.T he rapid mixing as well as enhanced heat and mass transfer in flow reactors allow better control of reaction selectivity. [1] An elegant example is the selective reduction of esters to aldehydes. [2] Extremely rapid lithiation reactions also showcase the unprecedented control of reactions in microreactors. [3] In addition, flow reaction technology enables much safer operation under conditions of high temperature and high pressure. [1e, 4] Several elegant examples of multistep synthesis have been performed in flow reactors, [5] but efficient telescoping of reactions still remains achallenge owing to needs for solvent switches, [5c,f-h,6a ] mismatch of flow rates, [5c,f-h] and necessity of workup.
[5a,g-h] Herein, we report at otal synthesis of ciprofloxacin in continuous flow,i nw hich six reactions are telescoped in five reactors sequentially without any separation or isolation of intermediates.T ot he best of our knowledge,t his is the longest linear sequence of reactions telescoped in flow to date,without holding the reaction stream. [7] Ciprofloxacin is on the World Health Organization List of Essential Medicines. [8] It belongs to the family of fluoroquinolone antibiotics and is used to treat anumber of types of bacterial infections.B ayer AG developed and patented as even-step synthesis in the 1980s,w ith an overall yield of 49 %and > 24 hofreaction time. [9] Later, asimilar sequence of reactions were performed on resin supported analog of 6 (Scheme 1), slightly increasing the overall yield to 57 %b ut with > 100 hreaction time. [10] Taking advantage of flow chemistry,w ea re aiming to increase the synthetic efficiency of ciprofloxacin. Our synthetic plan is shown in Scheme 1. Acylation of commercially available acyl chloride 8 with vinylogous carbamate 7 would afford 6.C iprofloxacin hydrochloride 1 would be generated after displacement with cyclopropylamine 5,t wo regioselective S N Ar reactions,hydrolysis of ester and acidification.
We started with screening solvents and bases for the acylation of vinylogous carbamate 7 with 8.A lthough 6 was obtained in good yields with ahandful of bases and solvents in batch, in the context of continuous flow synthesis,t he requirement to avoid generation of any precipitates needed to be satisfied. Three combinations of solvent/base were identified, acetonitrile/N,N-diisopropylethylamine (DIEA), chloroform/DIEA and chloroform/triethylamine (see the Supporting Information for details of screening). [11] Considering that the U.S. Food and Drug Administration (FDA) imposes ac oncentration limit of 60 ppm of chloroform and 410 ppm of acetonitrile, [12] we selected the combination of acetonitrile/DIEA. At 180 8 8Ca nd 175 psi, 98 %o f6 was generated with ar esidence time of 1.5 min. Addition of cyclopropylamine to the crude stream of 6 furnished exchange product 4 in 96 %i solated yield (Scheme 2).
Meanwhile,w ea lso investigated various batch reaction conditions for the direct acylation of 9,which was prepared by addition of 5 to 10 quantitatively either in batch or in flow. [13] When 9 was treated with weak bases,w eo btained am ixture of C-acylation( 4' ')a nd N-acylation (11)p roducts.U nder our best conditions,t he ratio of 4' ':11 was 6:1. [14] Moreover,t he reaction was much slower than acylationo f7,r eflecting significant difference in the nucleophilicity of both substrates (Scheme 3a). In contrast, when 9 was deprotonated with strong base n BuLi, followed by acylationw ith 8,c yclization product 3' '' ' immediately precipitated along with as mall amount of 4' ' (Scheme 3b). We did not optimize this set of conditions in flow,c onsidering both the intolerance of flow reactors with rapid precipitation of 3' '' ' and the higher cost of 10 than 7. [15] We continued our flow synthesis with the acylationexchange method. In agreement with Schwalbesr eport, [11] competitive substitution by HNMe 2 to form 3' ' (Scheme 4), [16] lowered the yield of desired cyclization product 3 to 24 %. Different from Schwalbe and co-workers who removed HNMe 2 by evaporation, which would otherwise result in discontinuous operation, we employed ar apid acylation reaction for the removal of HNMe 2 to ensure continuous operation. Simply by mixing the crude reaction mixture of 4 after exchange with acetyl chloride and DIEA at ambient temperature for ar esidence time of 1min, HNMe 2 was completely converted to N,N-dimethylacetamide (DMA), which did not interfere cyclization under the reaction conditions (Scheme 4a nd Scheme 5). Now the stage is set for cyclization. It is noteworthy that the solubility of 2 and 3 is low in av ariety of polar aprotic solvents suitable for S N Ar reactions at ambient temperature (e.g. solubility of 3 < 0.016 m in DMSO), possibly due to p-p stacking interactions,t herefore either higher temperature or high dilution is required for continuous flow synthesis to prevent clogging of reactors.A sw eo bserved that it took 1-2min for the crystals of 2/3 to nucleate when cooling from ah ot solution, we insulated related connections to prevent clogging. Initially we tried stepwise cyclization and S N Ar reaction and found aresidence time of 1.7 min was sufficient for the rapid intramolecular cyclization.Mixing the stream of 3 with astream of piperazine afforded 2 after aresidence time of 6.7 min. Hydrolysis and acidification afforded ciprofloxacin 13 in 86 %y ield. Inspired by the formation of side product 3' ',w ee nvisioned that one-pot cyclization and piperazine substitution may be feasible.I ndeed, when pure 4 was subjected to DBU and piperazine, 2 was obtained with 82 %y ield in batch. After some optimization (Table 1) , almost identical batch yield was observed when crude 4 after acetyl chloride treatment was used. Theo ne-pot reaction was monitored by 1 HNMR. 4 was first deprotonated to form one anionic species followed by cyclization and piperazine substitution sequentially.W ew ere then able to telescope the five reactions to afford 2 in 82 %overall yield in flow under optimized conditions (Scheme 4b and Scheme 5).
Mixing the stream of 2 with as tream of 1.0 m aqueous NaOH for ar esidence time of 0.9 min afforded the sodium carboxylate 12.A djusting the pH of the solution to 7w ith aqueous HCl offline enabled precipitation of crude cipro- In summary,wehave developed arapid total synthesis of ciprofloxacin in continuous flow.T he total residence time is 9minutes,c ompared to over 24 hours in patented synthesis [9, 14] and polymer supported synthesis. [10] The6 0% overall yield is comparable to batch [14] and semi-batch syntheses. [11] To the best of our knowledge,itisthe longest linear sequence of reactions telescoped in continuous flow to date without interrupting the flow by any workup requirements.T hrough meticulous selection of reaction conditions,o nly one inline workup step is required for the six-step sequence of reactions, in complement to modular flow synthesis. [5c, 18] Thek ey to continuous operation is 1) inline acylation of byproduct dimethylamine and 2) keeping the crude solution of 2 warm before entering Reactor Vtoavoid solid formation, due to its low solubility.Isolation of pure ciprofloxacin involves simple pH adjustment, filtration and washing. This synthesis enables significant reduction of reaction time and waste production. 
